10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). [electronic resource]
Producer: 20140417Description: 83-9 p. digitalISSN:- 1872-8332
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- mortality
- Chemoradiotherapy
- Cisplatin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Induction Chemotherapy
- Kaplan-Meier Estimate
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Prospective Studies
- Survivors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.